News & Events

TROBIX BIO selected as "One to watch" in this year SPINOFF PRIZE

6 July 2020
Trobix Bio and Ramot at Tel Aviv University are proud to announce that Trobix Bio has been selected as a “one to watch” for the Nature Research Spinoff Prize. This award is a steppingstone for sharing the story behind Trobix Bio’s technology, and a pier testimonial to the unique approach the company is taking to tackle antimicrobial resistance.

Lysogene partners with Weizmann Institute

1 July 2020
July 1, 2020 -- Lysogene has inked a research agreement with Yeda Research and Development, the commercial arm of the Weizmann Institute of Science, for novel gene therapy.

BAYER PHARMACEUTICALS will test new drugs using human heart tissues 3D-Printed in Tel Aviv University

29 June 2020
Ramot at Tel Aviv University signed a collaboration agreement with Bayer to develop and validate a platform for in vitro cardiotoxicity screening, using human heart tissues 3D-printed in Prof. Tal Dvir’s Laboratory for Tissue Engineering and Regenerative Medicine. In upcoming years, Prof. Dvir’s team and Bayer plan to test new medication for toxicity and efficacy using printed whole human hearts.

Immunodominant epitopes identified for designing based vaccine against SARS -COV 2

14 June 2020
In a study just published in the journal MDPI Vaccines, researchers from Bar-Ilan University have identified a set of potential immunodominant epitopes from the SARS-CoV-2 proteome.

Researchers develop technology that transforms tap water into powerful enviromentally - friendly disinfectant against viruses, including Coronavirus

08 June 2020
searchers from Bar-Ilan University have developed new methodologies to produce powerful, environmentally-friendly disinfectants, based on tap water, that can eliminate bacteria and kill viruses, including microbes from the coronavirus family. The ability to turn ordinary tap water into virus-fighting materials was developed and patented by Dr. Eran Avraham, Dr. Izaak Cohen, and Prof. Doron Aurbach

RAMOT@TAU is collaborating with Biological Industries ISRAEL BEIT HAEMEK LTD. and THE ISRAEL DEFENSE FORCES (IDF) to detect antibodies and immune response to Cornavirus using a highly sensitive and specific serological assay developed at TAU

18 May 2020
A TAU team led by Prof. Motti Gerlic and Prof. Ariel Munitz, both of TAU's Sackler Faculty of Medicine of Tel Aviv University, have developed a new test to add to the current diagnostic arsenal used to detect coronavirus infection. The unique test is serological — a blood test — and measures the presence of three type of antibodies against the virus.

Prof. Gabby Sarusi Develops One Minute Coronavirus Test

13 May 2020
BEER-SHEVA, Israel, May 13, 2020 – Ben-Gurion University of the Negev's Prof. Gabby Sarusi has developed and is now validating a test that identifies carriers of the COVID-19 virus in less than a minute with greater than 90% accuracy and at a dramatically lower price than any other method available

NEOVII to develop a novel vaccine for Covid -19 in an exclusive partnershipa with RAMOT@TAU

12 May 2020
Rapperswil, Switzerland, Tel Aviv, Israel, May 12, 2020, Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology to develop a novel and potentially life-saving COVID-19 vaccine.

BGU Scientists Develop Anti-Coronavirus Surface Coating Based on Nanomaterials

05 May 2020
Prof. Angel Porgador, from the Department of Microbiology, Immunology and Genetics at Ben-Gurion University (BGU) and the National Institute of Biotechnology in the Negev (NIBN), and Dr. Mark Schvartzman, the Department of Materials Engineering at BGU, are developing novel surface coatings that will have a long term effect, and contain nanoparticles of safe metal ions and polymers
with anti-viral and anti-microbial activity.

Jerusalem researchers say they’ve developed injection to fight superbugs

05 May 2020
One scientist asserts new treatment, which allows previously topical drug to be administered intravenously, is ‘a game-changer’ in the battle against antibiotic-resistant bacteria.